Effectiveness and safety of anti-BCMA chimeric antigen receptor T-cell treatment in relapsed/refractory multiple myeloma: a comprehensive review and meta-analysis of prospective clinical trials

• Main Authors: Dingyuan Hu (Author), Liming Chen (Author), Diqin Yan (Author), Wenliang Dong (Author), Min Chen (Author), Suping Niu (Author), Simin Wang (Author), Jiaojiao Zhang (Author), Xiaoyan Nie (Author), Yi Fang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Chimeric antigen receptor T cells treatment targeting B cell maturation antigen (BCMA) is an emerging treatment option for relapsed/refractory multiple myeloma (RRMM) and has demonstrated outstanding outcomes in clinical studies.Objective: The aim of this comprehensive review and meta-an...